Allarity Therapeutics

📍 Boston, United States🗓 Founded 2012👥 14 employees💰 Last funded Oct 2020
Pharmaceutical Manufacturing🌐 allarity.com
Website LinkedIn
Allarity Therapeutics (Nasdaq: ALLR) is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Publicly traded on NASDAQ, Allarity (ALLR) is headquartered in Boston, MA, while maintaining an R&D facility in Hoersholm, Denmark. Allarity is committed to enhancing patient outcomes through improved decision-making and personalized cancer care.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2012
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Denmark
1
United States
1
Frequently asked questions
Who invested in Allarity Therapeutics?
Allarity Therapeutics has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Allarity Therapeutics last raise funding?
The most recent investment in Allarity Therapeutics recorded on gritt.io was in October 2020.
When was Allarity Therapeutics founded?
Allarity Therapeutics was founded in 2012.
What industry is Allarity Therapeutics in?
Allarity Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Allarity Therapeutics based?
Allarity Therapeutics is headquartered in Boston, United States.